Tirofiban for acute ischemic stroke: systematic review and meta-analysis Jinhong GongJingjing ShangGuangjun Liu Review 03 January 2020 Pages: 475 - 481
Intake of aspirin prior to metamizole does not completely prevent high on treatment platelet reactivity Christian PfrepperCarolin DietzeSirak Petros Clinical Trial 08 January 2020 Pages: 483 - 490
Aripiprazole for prevention of delirium in the neurosurgical intensive care unit: a double-blind, randomized, placebo-controlled study Majid MokhtariMaryam FarasatinasabMohammad Sistanizad Clinical Trial 03 January 2020 Pages: 491 - 499
Sufentanil versus fentanyl for pain relief in labor involving combined spinal-epidural analgesia: a systematic review and meta-analysis of randomized controlled trials Mengjia ZhiYifan DiaoYuanli Liu Clinical Trial 07 January 2020 Pages: 501 - 506
WHO guide to good prescribing is 25 years old: quo vadis? J. TichelaarM. C. RichirTh. P. G. M. de Vries Special Article Open access 14 January 2020 Pages: 507 - 513
Variability of voriconazole concentrations in patients with hematopoietic stem cell transplantation and hematological malignancies: influence of loading dose, procalcitonin, and pregnane X receptor polymorphisms Guangting ZengLinlin WangZanling Zhang Pharmacogenetics 14 January 2020 Pages: 515 - 523
Cardiovascular drug use among people with cognitive impairment living in nursing homes in northern Sweden Sofia SvahnHugo LövheimMaria Gustafsson Pharmacoepidemiology and Prescription Open access 08 January 2020 Pages: 525 - 537
Differences in medical treatment and clinical characteristics between men and women with heart failure – a single-centre multivariable analysis Helena NorbergVeronica PranicKrister Lindmark Pharmacoepidemiology and Prescription Open access 03 January 2020 Pages: 539 - 546
Consumption of medicines used for gastric acid-related disorders in Australia and South Korea: a cross-country comparison Su-Yeon YuBoram LeeSamantha A. Hollingworth Pharmacoepidemiology and Prescription 10 December 2019 Pages: 547 - 555
Clinical evidence supporting the marketing authorization of biosimilars in Europe Eleonora AllocatiVittorio Bertele’Rita Banzi Pharmacoepidemiology and Prescription 02 January 2020 Pages: 557 - 566
Multidisciplinary perspectives on medication-related decision-making for people with advanced dementia living in long-term care: a critical incident analysis Domenica DisalvoTim LuckettMeera Agar Pharmacoepidemiology and Prescription 14 January 2020 Pages: 567 - 578
Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors Camille AzamPauline ClarazFlorent Puisset Pharmacoepidemiology and Prescription 13 January 2020 Pages: 579 - 587
Longitudinal model–based meta-analysis for survival probabilities in patients with castration-resistant prostate cancer Wenjun ChenLiang LiTianyan Zhou Pharmacodynamics 10 January 2020 Pages: 589 - 601
Myocardial infarction and ischemic stroke with vasoconstrictors used as nasal decongestant for common cold: a French pharmacovigilance survey Margaux LafauriePascale OlivierJean-Louis Montastruc Letter to the Editor 20 December 2019 Pages: 603 - 604
Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report Dario CattaneoTiziana FormentiCristina Gervasoni Letter to the Editor 03 January 2020 Pages: 605 - 606
Is cinnarizine/betahistine combination superior to respective monotherapies in treatment of vertigo? Comment on a randomized triple-blind placebo-controlled trial Kiumarth AminiMaryam Taghizadeh-Ghehi Letter to the Editor 14 January 2020 Pages: 607 - 608
Comment on “Is cinnarizine/betahistine combination superior to respective monotherapies in treatment of vertigo? A randomized triple-blind placebo-controlled trial” Alireza MajdiSeyed Ahmad Naseri Alavi Letter to the Editor 13 January 2020 Pages: 609 - 610